[{"Assets_0_Q3_USD":45356000.0,"CommonStockSharesOutstanding_0_Q3_shares":159497573.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-62719000.0,"NetIncomeLoss_1_Q3_USD":-24168000.0,"NetIncomeLoss_3_Q3_USD":-77224000.0,"StockholdersEquity_0_Q3_USD":-205441000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":4469000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":11827000.0,"Ticker":"MNKD","CIK":"899460","name":"MANNKIND CORP","OfficialName":"MannKind Corporation Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"898029416.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181101"}]